IKGPF yields 425.53% · JNJ yields 2.13%● Live data
📍 IKGPF pulled ahead of the other in Year 1
Combined, IKGPF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IKGPF + JNJ for your $10,000?
ikeGPS Group Limited, together with its subsidiaries, engages in the design, sale, and delivery of a solution for the collection, analysis, and management of distribution assets for electric utilities and communications companies in the United States. It operates in two segments, Utilities and Communications, and Other Business. The company offers IKE Office, a cloud platform that enables customers to measure and manage pole projects and data, as well as user can export IKE records to their native systems; IKE Structural, a PoleForeman and Sagline software product that performs pole load analysis; IKE Insight that enables users gain actionable insights from bulk data and images using artificial intelligence and predictive analytics. It also provides IKE Analyze for heights of attachment, pole load analysis, and make ready recommendations; and IKE University for pole audit and analysis training. The company was formerly known as Surveylab Group Limited and changed its name to ikeGPS Group Limited in October 2013. ikeGPS Group Limited was incorporated in 2003 and is headquartered in Broomfield, Colorado.
Full IKGPF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.